Advancing physiological maturation in human induced pluripotent stem cell-derived cardiac muscle by gene editing an inducible adult troponin isoform switch
- 4 June 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 38 (10) , 1254-1266
Abstract
Advancing maturation of stem cell-derived cardiac muscle represents a major barrier to progress in cardiac regenerative medicine. Cardiac muscle maturation involves a myriad of gene, protein, and cell-based transitions, spanning across all aspects of cardiac muscle form and function. We focused here on a key developmentally controlled transition in the cardiac sarcomere, the functional unit of the heart. Using a gene-editing platform, human induced pluripotent stem cell (hiPSCs) were engineered with a drug-inducible expression cassette driving the adult cardiac troponin I (cTnI) regulatory isoform, a transition shown to be a rate-limiting step in advancing sarcomeric maturation of hiPSC cardiac muscle (hiPSC-CM) toward the adult state. Findings show that induction of the adult cTnI isoform resulted in the physiological acquisition of adult-like cardiac contractile function in hiPSC-CMs in vitro. Specifically, cTnI induction accelerated relaxation kinetics at baseline conditions, a result independent of alterations in the kinetics of the intracellular Ca2+ transient. In comparison, isogenic unedited hiPSC-CMs had no cTnI induction and no change in relaxation function. Temporal control of adult cTnI isoform induction did not alter other developmentally regulated sarcomere transitions, including myosin heavy chain isoform expression, nor did it affect expression of SERCA2a or phospholamban. Taken together, precision genetic targeting of sarcomere maturation via inducible TnI isoform switching enables physiologically relevant adult myocardium-like contractile adaptations that are essential for beat-to-beat modulation of adult human heart performance. These findings have relevance to hiPSC-CM structure-function and drug-discovery studies in vitro, as well as for potential future clinical applications of physiologically optimized hiPSC-CM in cardiac regeneration/repair.Keywords
Funding Information
- National Institutes of Health
- Regenerative Medicine Minnesota
- Summer's Wish Pediatric Cardiology Innovators Fund
- Warwick Foundation
This publication has 45 references indexed in Scilit:
- Direct, Differential Effects of Tamoxifen, 4-Hydroxytamoxifen, and Raloxifene on Cardiac Myocyte Contractility and Calcium HandlingPLOS ONE, 2013
- Noncanonical EF-hand motif strategically delays Ca2+ buffering to enhance cardiac performanceNature Medicine, 2013
- Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signalingProceedings of the National Academy of Sciences, 2012
- pH-Responsive Titratable Inotropic Performance of Histidine-Modified Cardiac Troponin IBiophysical Journal, 2012
- Constitutive Gs activation using a single-construct tetracycline-inducible expression system in embryonic stem cells and miceStem Cell Research & Therapy, 2011
- Pathogenic peptide deviations support a model of adaptive evolution of chordate cardiac performance by troponin mutationsPhysiological Genomics, 2010
- Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleasesNature Biotechnology, 2009
- Human Induced Pluripotent Stem Cells Free of Vector and Transgene SequencesScience, 2009
- Single histidine button in cardiac troponin I sustains heart performance in response to severe hypercapnic respiratory acidosis in vivoThe FASEB Journal, 2009
- Cardiac Transgenic and Gene Transfer Strategies Converge to Support an Important Role for Troponin I in Regulating Relaxation in Cardiac MyocytesCirculation Research, 2007